Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2003
10/07/2003US6630337 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/07/2003US6630336 Peptides; for use as tools in human therapeutics and diagnostic testing
10/07/2003US6630331 Isolated DNA encoding a protein from Lotus japonicus which has pantothenate synthetase activity; enzyme inhibitors
10/07/2003US6630329 Generating a library of mutant nucleotide sequences; obtain nucleotide sequences, incubate with primers, amplification reaction mixture and inosine, amplify, recover mutant nucleotide sequences
10/07/2003US6630326 Cancer diagnosis and therapy based on mutations in TGF-β receptors
10/07/2003US6630321 Switching off expression via a promoter; contacting cells with the candidate drug; useful in high throughput screening for antimicrobial agents
10/07/2003US6630318 Prognostic evaluation of cancer
10/07/2003US6630317 Methods for obtaining, identifying and applying nucleic acid sequences and (poly)peptides which increase the expression yields of periplasmic proteins in functional form
10/07/2003US6630316 Method for measurement of lymphocyte function
10/07/2003US6630313 Phosphatidyl serine receptors and uses thereof
10/07/2003US6630312 Method for identifying compounds for treatment of insulin resistance
10/07/2003US6630311 Fluorescence-based high throughput screening assays for protein kinases and phosphatases
10/07/2003US6630308 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
10/07/2003US6630306 Bioreactive allosteric polynucleotides
10/07/2003US6630304 Human osteoporosis gene
10/07/2003US6630303 Methods of screening for compounds active on Staphylococcus aureus target genes
10/07/2003US6630302 Isolating DNA encoding ribosomal RNA; digesting with restriction enzymes, separating the fragments and comparing the signature bands of the digestion product with a control
10/07/2003US6630301 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum
10/07/2003US6630300 Nucleotide sequences for use in the detection of viral infection of foods
10/07/2003US6630297 Methods of screening for agents that modulate the interaction of human ECT2 polypeptide with an ECT2 binding target
10/07/2003US6630296 Monitoring the activity of preferential enzymes; obtain sample containing enzymes, incubate with substrate, monitor adjustment in enzyme activity
10/07/2003US6630295 Monitoring molecular weight adjustment in ionic compound; obtain chemical intermediates, incubate with fluorescent dyes, monitor fluorescence polarization to detect molecular weight adjustment
10/07/2003US6630294 Identifying a agent which increases nonsense suppression by detecting binding to the enzyme; Saccharomyces; use in treating genetic disorders that are a result of nonsense mutations
10/07/2003CA2256457C Passive internal references for the detection of nucleic acid amplification products
10/07/2003CA2221522C Quenching reagents and assays for enzyme-mediated luminescence
10/07/2003CA2211204C Prostaglandin receptor dp
10/07/2003CA2068471C Reagent and method for analyzing cells in urine
10/02/2003WO2003081509A2 DATA MINING OF SNP DATABASES FOR THE SELECTION OF INTRAGENIC SNPs
10/02/2003WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
10/02/2003WO2003081257A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1)
10/02/2003WO2003081254A1 Protein profiling of hyper acidic plants
10/02/2003WO2003081252A1 Arrays
10/02/2003WO2003081251A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003WO2003081250A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003WO2003081249A2 Method for the detection of prion proteins
10/02/2003WO2003081242A1 Caspr3: modulators of angiogenesis
10/02/2003WO2003081239A2 Treating cancer
10/02/2003WO2003081238A2 Cytocapacity test
10/02/2003WO2003081234A2 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8)
10/02/2003WO2003081210A2 Identification of kinase inhibitors
10/02/2003WO2003081209A2 Identification of ligands for a receptor family and related methods
10/02/2003WO2003081206A2 Stratification of patient populations having or suspected of having rheumatoid arthritis
10/02/2003WO2003081204A2 Microscale sensor element and related device and method of manufacture
10/02/2003WO2003081202A2 Bioconjugate-nanoparticle probes
10/02/2003WO2003081201A2 Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
10/02/2003WO2003080871A2 Method for detection and differentiation of mycobacterium tuberculosis complex
10/02/2003WO2003080870A1 Polynucleotide primers and probes for rapid detection of group b streptococcus (gbs)
10/02/2003WO2003080869A2 Storing and detecting nucleic acid administered to a solid carrier
10/02/2003WO2003080866A1 Novel primers for identifying aflatoxinogenic aspergilli and an improved use thereof
10/02/2003WO2003080865A1 Primers for detecting food poisoning bacteria and a use thereof
10/02/2003WO2003080864A1 Histone deacetylase: novel molecular target of neurotoxicity
10/02/2003WO2003080863A1 Method for the analysis of methylation patterns within nucleic acids by means of mass spectrometry
10/02/2003WO2003080862A1 Method and devices for dna methylation analysis
10/02/2003WO2003080861A1 Single molecule sequencing using phosphate labeled nucleotides
10/02/2003WO2003080860A1 A quick and sensitive method of quantifying mycolic acid
10/02/2003WO2003080859A1 Tryptophan aminotransferase, indole-3-pyruvate decarboxylase and indole-3-acetaldehyde oxidase as novel targets for herbicides
10/02/2003WO2003080857A2 Pna oligomers, oligomers sets, methods and kits pertaining to the detection of bacillus anthracis
10/02/2003WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003WO2003080853A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003WO2003080840A1 A method of inspecting the genetic susceptibility of h.pylori related gastric carcinoma and the use of it
10/02/2003WO2003080836A1 Nerve regeneration genes
10/02/2003WO2003080831A1 Nuclear receptor errϝ3
10/02/2003WO2003080825A2 Further bmp-2 inducible kinases and the uses thereof
10/02/2003WO2003080824A1 Hapatitis b viral packaging system
10/02/2003WO2003080823A2 Bacteriophages useful for therapy and prophylaxis of bacterial infections
10/02/2003WO2003080808A2 Novel compositions and methods in cancer
10/02/2003WO2003080799A2 Polymorphic repetitive sequences in chlamydiae and uses thereof
10/02/2003WO2003080736A1 Use of oxazine dyes as marking groups for single molecule analysis
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080661A1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases
10/02/2003WO2003080645A2 Amplification of nucleic acid fragments using nicking agents
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080639A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003WO2003080570A2 Recombinant expression vectors for functional nav1.9 sodium channels
10/02/2003WO2003080209A2 Method of concentrating macromolecules or agglomerates of molecules or particles
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080100A2 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 63 (gpr63)
10/02/2003WO2003080097A2 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 7 (gpr7)
10/02/2003WO2003080000A2 Modulation of angiogenesis through targeting of cysteine oxygenase activity
10/02/2003WO2003079999A2 Modulation of angiogenesis through targeting of arginyl transferase (ate1)
10/02/2003WO2003079996A2 Process for preparing purified s-bel and r-bel and compositions thereof
10/02/2003WO2003079987A2 A non-selective cation channel in neural cells and methods for treating brain swelling
10/02/2003WO2003079982A2 Gene amplification in cancer
10/02/2003WO2003079977A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003WO2003079884A2 Methods for diagnosis and prognosis of cancer
10/02/2003WO2003079757A2 Hiv therapeutic
10/02/2003WO2003079747A2 An isolated polynucleotide associated with type ii diabetes mellitus and methods of use thereof
10/02/2003WO2003064441A3 Oligonucleotides comprising alternating segments and uses thereof
10/02/2003WO2003062414A3 Methods of obtaining isoform specific expression in mammalian cells
10/02/2003WO2003062394A9 Methods and compositions for rna interference
10/02/2003WO2003060121A9 Compositions and methods relating to gastric specific genes and proteins
10/02/2003WO2003052143A3 New primers for the detection and identification of bacterial indicator groups and virulence factors
10/02/2003WO2003052133A3 Oligonucleotide analogues comprising intercalator pseudonucleotides
10/02/2003WO2003048299A3 Novel spore wall proteins and genes from microsporidia
10/02/2003WO2003047037A9 Fabrication of a high resolution biological molecule detection device with aluminum electrical conductors
10/02/2003WO2003046213A3 Method for concentrating and detecting hiv
10/02/2003WO2003046180A3 Human cdnas and proteins and uses thereof
10/02/2003WO2003031649A3 Method for the determination of cytosine methylation in cpg islands
10/02/2003WO2003023363A3 Microcantilever apparatus and methods for detection of enzymes
10/02/2003WO2003015692A3 Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same
1 ... 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 ... 3003